Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles

Objective To evaluate reproductive hormone patterns in women exposed to alkylating-agent chemotherapy. Design Prospective cohort. Setting University hospital. Patient(s) Normally menstruating mid-reproductive-age women (20–35 years old) who had previously been exposed to alkylating-agent chemotherap...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Fertility and sterility 2016-12, Vol.106 (7), p.1793-1799.e2
Hauptverfasser:	Johnson, Lauren, M.D., M.S.C.E, Sammel, Mary D., Sc.D, Schanne, Allison, B.A, Lechtenberg, Lara, B.A, Prewitt, Maureen, B.S.N, Gracia, Clarisa, M.D., M.S.C.E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Antineoplastic Agents, Alkylating - adverse effects Biomarkers - urine cancer survivors Case-Control Studies E1c Estrone - analogs & derivatives Estrone - urine Female Follicle Stimulating Hormone, Human - urine Glucuronides - urine Hospitals, University Humans Internal Medicine Luteinizing Hormone - urine Middle Aged Obstetrics and Gynecology Ovarian Reserve - drug effects Ovulation - drug effects PDG Pregnanediol - analogs & derivatives Pregnanediol - urine Progesterone excretion Prospective Studies Urinalysis urinary hormones Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!